Biotime Announces Distribution Ratio For Distribution Of Agex Therapeutics Shares | Latest News RSS feed

Biotime Announces Distribution Ratio For Distribution Of Agex Therapeutics Shares - Latest News


BioTime Announces Distribution of AgeX Therapeutics Shares

Distribution ... by AgeX Therapeutics, Inc. (“AgeX”), was declared effective by the Securities and Exchange Commission (“SEC”) on November 27, 2018, and that BioTime will proceed with the distribution ... read more

BioTime updates timeline for distribution of AgeX shares to Biotime shareholders

BioTime (NYSEMKT:BTX) announces that its Board of Directors intends to set a new record date for the distribution of AgeX Therapeutics shares to BioTime shareholders. The ratio of one share of AgeX co... read more

BioTime Board of Directors Approves Distribution of AgeX Therapeutics Shares to BioTime Shareholders

announced today that its Board of Directors has approved a distribution of some or all of the shares of AgeX Therapeutics, Inc. owned by BioTime to BioTime’s shareholders. The Board also authorized ma... read more

Looking for another news?


BioTime Reports Third Quarter Results and Recent Corporate Accomplishments

New Subsidiary AgeX Therapeutics, Inc. BioTime Board of Directors approved a distribution of some or all of the shares of AgeX Therapeutics, Inc. owned by BioTime to BioTime’s shareholders. The Board ... read more


BioTime Inc Shares Outstanding

Shares outstanding represents a company's market value spread across the amount of shares outstanding. The amount of shares outstanding is frequently used in ratios such as Earnings Per Share. read more

BioTime Announces Distribution of AgeX Therapeutics Shares

BioTime ... on degenerative diseases, today announced that the registration statement on Form 10, including the information statement relating to the distribution that was previously prepared and file... read more

BioTime Announces Distribution Ratio for Distribution of AgeX Therapeutics Shares

BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that its Board of Directors has set the distribution ratio for the distribu... read more

BioTime announces record date for the distribution of AgeX Therapeutics shares

BioTime (BTX +2.8%) has set July 31 record date for the distribution of AgeX Therapeutics shares. The final distribution ratio will be determined by the BioTime Board. BioTime expects the distribution ... read more

BioTime Announces Distribution Ratio for Distribution of AgeX Therapeutics Shares

BioTime shareholders will receive one share of AgeX common stock for every 10 shares of BioTime common stock held BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us